Evolus Inc.https://investorshangout.com/Evolus-Inc-EOLS-92736/en-usMon, 19 Oct 2026 13:11:08 GMTCopyright InvestorsHangout.comwhytestocks: $EOLS News Article - Evolus Set For Promising 2024: Analysts Maintain Positive Outlook On Botox Altehttps://investorshangout.com/post/view?id=6664004https://investorshangout.com/post/view?id=6664004Wed, 17 Jan 2024 21:10:44 GMTwhytestocks: $EOLS News Article - Evolus Inc. (NASDAQ: EOLS) Leading the Way in Wednesday Trading Based on Percenhttps://investorshangout.com/post/view?id=6663853https://investorshangout.com/post/view?id=6663853Wed, 17 Jan 2024 16:05:45 GMTwhytestocks: $EOLS News Article - Botox And Similar Injections Have Associated Risks: Consumer Group Pushes for Shttps://investorshangout.com/post/view?id=6652924https://investorshangout.com/post/view?id=6652924Tue, 12 Dec 2023 21:00:51 GMTAviseAnalytics: EVOLUS: NEXT BIG THING IN THE PERFORMANCE BEAUTY INDUSTRY $EOLS Excited to sharehttps://investorshangout.com/post/view?id=6604430https://investorshangout.com/post/view?id=6604430Fri, 04 Aug 2023 12:37:05 GMTwhytestocks: $EOLS News Article - Why Shares of Evolus Are Jumping Thursday https://investorshangout.com/post/view?id=6601404https://investorshangout.com/post/view?id=6601404Thu, 27 Jul 2023 15:55:47 GMTwhytestocks: $EOLS News Article - Evolus to Present Phase 2 Interim Data from Jeuveau "Extra-Strength" Dose for https://investorshangout.com/post/view?id=6525818https://investorshangout.com/post/view?id=6525818Mon, 23 Jan 2023 13:45:52 GMTwhytestocks: $EOLS News Article - Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Net Rehttps://investorshangout.com/post/view?id=6524019https://investorshangout.com/post/view?id=6524019Wed, 18 Jan 2023 15:00:54 GMTwhytestocks: $EOLS News Article - Evolus Extends Term of Credit Facility with Pharmakon Advisors https://investorshangout.com/post/view?id=6508730https://investorshangout.com/post/view?id=6508730Thu, 08 Dec 2022 16:55:47 GMTwhytestocks: $EOLS News Article - Evolus Reports Fourth Quarter and Full Year 2020 Results and Provides Business https://investorshangout.com/post/view?id=6090914https://investorshangout.com/post/view?id=6090914Wed, 24 Mar 2021 20:25:49 GMTwhytestocks: $EOLS News Article - Evolus Strengthens Balance Sheet Through a $25.5 Million Cash Infusion and Elimhttps://investorshangout.com/post/view?id=6089218https://investorshangout.com/post/view?id=6089218Tue, 23 Mar 2021 15:05:49 GMTznewcar1: EOLS 71% v33,6M c12.29 f33,7M morning gapNgo from 7.1 yesterdays close to a HOD14.81 got S@10.4 thenhttps://investorshangout.com/post/view?id=6060020https://investorshangout.com/post/view?id=6060020Fri, 19 Feb 2021 21:23:32 GMTwhytestocks: $EOLS News Article - AbbVie, Evolus, and Medytox Announce Resolution of Intellectual Property Litigahttps://investorshangout.com/post/view?id=6059276https://investorshangout.com/post/view?id=6059276Fri, 19 Feb 2021 15:10:48 GMTznewcar1: EOLS 21% v6,3M c4.46 f33,7M preMH5.6 H5.09 S4.18https://investorshangout.com/post/view?id=5993971https://investorshangout.com/post/view?id=5993971Thu, 17 Dec 2020 22:50:57 GMTwhytestocks: $EOLS must see https://investorshangout.com/post/view?id=5778064https://investorshangout.com/post/view?id=5778064Tue, 26 May 2020 16:25:45 GMTwhytestocks: $EOLS News Article - Evolus Expands Board of Directors with Appointment of Independent Directors Pethttps://investorshangout.com/post/view?id=5483601https://investorshangout.com/post/view?id=5483601Mon, 15 Jul 2019 15:55:40 GMTwhytestocks: $EOLS News Article - Evolus Accelerates Next Phase of U.S. Launch of Jeuveau(TM) with '#NEWTOX NOW' https://investorshangout.com/post/view?id=5454423https://investorshangout.com/post/view?id=5454423Wed, 05 Jun 2019 14:45:41 GMTwhytestocks: $EOLS News Article - Evolus Announces Publication of U.S. Phase III Pivotal Trial Results for Jeuveahttps://investorshangout.com/post/view?id=5387683https://investorshangout.com/post/view?id=5387683Thu, 21 Mar 2019 18:45:40 GMTznewcar1: 20.16% 4,837,213 28.91 27,274,991 Still going!https://investorshangout.com/post/view?id=5342391https://investorshangout.com/post/view?id=5342391Thu, 07 Feb 2019 21:50:32 GMTznewcar1: 26.00% v6,892,778 c25.83 f27,274,991 News big recent vol. is impressive FDA approval.https://investorshangout.com/post/view?id=5339308https://investorshangout.com/post/view?id=5339308Tue, 05 Feb 2019 21:31:10 GMT